Radiothérapie postopératoire des cancers de la prostate : à quel moment la proposer ? Quelle place pour la déprivation androgènique ?

While there is no high-level evidence showing superiority of surgery over radiation treatment, radical prostatectomy is the most common treatment option for patients with localized, non-metastatic disease. Nearly 30% of all patients undergoing surgery will develop a biochemical recurrence in 10 years. In fact, more than 30% of contemporary patients treated with RP will harbor aggressive disease characteristics at final pathology.We conducted a...